Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
Clinical trial NCT05380453 · COMPLETED
Trial details
- NCT number
- NCT05380453
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2026-02-24
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.